Ratio Review: Analyzing Universal Technical Institute Inc (UTI)’s Price-to-Cash and Price-to-Free Cash Flow

Abby Carey

The pursuit of outperformance leads many investors to carefully choose individual stocks. Picking the right ones can be a game-changer for growing your wealth.

After finishing at $24.46 in the prior trading day, Universal Technical Institute Inc (NYSE: UTI) closed at $24.7, up 0.98%. In other words, the price has increased by $0.98 from its previous closing price. On the day, 0.76 million shares were traded. UTI stock price reached its highest trading level at $25.105 during the session, while it also had its lowest trading level at $24.02.

Ratios:

Our goal is to gain a better understanding of UTI by taking a closer look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 7.64 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 24.29. For the most recent quarter (mrq), Quick Ratio is recorded 1.07 and its Current Ratio is at 1.07. In the meantime, Its Debt-to-Equity ratio is 0.85 whereas as Long-Term Debt/Eq ratio is at 0.79.

On July 25, 2024, Truist started tracking the stock assigning a Buy rating and target price of $22.

On January 10, 2024, Northland Capital started tracking the stock assigning a Outperform rating and target price of $16.Northland Capital initiated its Outperform rating on January 10, 2024, with a $16 target price.

Insider Transactions:

The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Dec 03 ’25 when Coliseum Capital Management, L bought 355,236 shares for $24.81 per share. The transaction valued at 8,814,053 led to the insider holds 3,779,610 shares of the business.

Coliseum Capital Management, L bought 191,830 shares of UTI for $4,868,645 on Dec 05 ’25. The Director now owns 3,971,440 shares after completing the transaction at $25.38 per share. On Dec 02 ’25, another insider, Coliseum Capital Management, L, who serves as the Director of the company, bought 467,020 shares for $24.40 each. As a result, the insider paid 11,395,288 and bolstered with 3,424,374 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, UTI now has a Market Capitalization of 1344417792 and an Enterprise Value of 1453760768. As of this moment, Universal’s Price-to-Earnings (P/E) ratio for their current fiscal year is 21.77, and their Forward P/E ratio for the next fiscal year is 27.94. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.61 while its Price-to-Book (P/B) ratio in mrq is 4.10. Its current Enterprise Value per Revenue stands at 1.74 whereas that against EBITDA is 12.482.

Stock Price History:

The Beta on a monthly basis for UTI is 1.38, which has changed by -0.061036468 over the last 52 weeks, in comparison to a change of 0.13042927 over the same period for the S&P500. Over the past 52 weeks, UTI has reached a high of $36.32, while it has fallen to a 52-week low of $21.29. The 50-Day Moving Average of the stock is -14.40%, while the 200-Day Moving Average is calculated to be -16.48%.

Shares Statistics:

The stock has traded on average 777.95K shares per day over the past 3-months and 1047290 shares per day over the last 10 days, according to various share statistics. A total of 54.43M shares are outstanding, with a floating share count of 52.43M. Insiders hold about 3.68% of the company’s shares, while institutions hold 95.48% stake in the company. Shares short for UTI as of 1764288000 were 2134338 with a Short Ratio of 2.74, compared to 1761868800 on 1945035. Therefore, it implies a Short% of Shares Outstanding of 2134338 and a Short% of Float of 4.62.

Earnings Estimates

The market rating for Universal Technical Institute Inc (UTI) is a result of the insights provided by 6.0 analysts actively involved in the assessment.The consensus estimate for the next quarter is $0.07, with high estimates of $0.13 and low estimates of $0.03.

Analysts are recommending an EPS of between $0.78 and $0.71 for the fiscal current year, implying an average EPS of $0.76. EPS for the following year is $0.88, with 5.0 analysts recommending between $0.93 and $0.84.

Revenue Estimates

6 analysts predict $216.65M in revenue for. The current quarter. It ranges from a high estimate of $218.57M to a low estimate of $214.91M. As of. The current estimate, Universal Technical Institute Inc’s year-ago sales were $201.43MFor the next quarter, 6 analysts are estimating revenue of $222.67M. There is a high estimate of $226.71M for the next quarter, whereas the lowest estimate is $219.7M.

A total of 6 analysts have provided revenue estimates for UTI’s current fiscal year. The highest revenue estimate was $910.8M, while the lowest revenue estimate was $905M, resulting in an average revenue estimate of $908.41M. In the same quarter a year ago, actual revenue was $835.62MBased on 5 analysts’ estimates, the company’s revenue will be $988.81M in the next fiscal year. The high estimate is $992.49M and the low estimate is $985M.

DwinneX
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.